<qa>  What is the name of the inhibitors of Dipeptidyl peptidase IVIncretinomimetics include exogenous Glucagon-Like Peptide analogs GLP1a such as Liraglutide, and inhibitors of Dipeptidyl peptidase IV DPP4i that prolong the half-life of endogenous GLP1 such as Vildagliptin. It remains unclear which of the two strategies exogenous GLP1 or prolonging half-life of endogenous GLP1 have better short term effect on insulin sensitivity and insulin secretion in people living with type 2 diabetes. 